PR
Payden & Rygel’s Medtronic MDT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-120,900
| Closed | -$10.7M | – | 144 |
|
2023
Q2 | $10.7M | Buy |
120,900
+13,400
| +12% | +$1.18M | 0.75% | 64 |
|
2023
Q1 | $8.67M | Buy |
107,500
+106,000
| +7,067% | +$8.55M | 0.51% | 74 |
|
2022
Q4 | $117K | Hold |
1,500
| – | – | 0.01% | 130 |
|
2022
Q3 | $121K | Sell |
1,500
-45,400
| -97% | -$3.66M | 0.01% | 131 |
|
2022
Q2 | $4.21M | Sell |
46,900
-276,400
| -85% | -$24.8M | 0.25% | 72 |
|
2022
Q1 | $35.9M | Buy |
323,300
+195,130
| +152% | +$21.6M | 1.81% | 15 |
|
2021
Q4 | $13.3M | Buy |
128,170
+120,470
| +1,565% | +$12.5M | 0.61% | 71 |
|
2021
Q3 | $965K | Hold |
7,700
| – | – | 0.05% | 92 |
|
2021
Q2 | $956K | Sell |
7,700
-224,680
| -97% | -$27.9M | 0.05% | 97 |
|
2021
Q1 | $27.5M | Buy |
232,380
+6,300
| +3% | +$744K | 1.28% | 38 |
|
2020
Q4 | $26.5M | Buy |
226,080
+3,980
| +2% | +$466K | 1.36% | 38 |
|
2020
Q3 | $23.1M | Sell |
222,100
-130,800
| -37% | -$13.6M | 1.37% | 37 |
|
2020
Q2 | $32.4M | Sell |
352,900
-11,400
| -3% | -$1.05M | 2.06% | 12 |
|
2020
Q1 | $32.9M | Buy |
364,300
+29,958
| +9% | +$2.7M | 2.37% | 12 |
|
2019
Q4 | $37.9M | Buy |
334,342
+32,400
| +11% | +$3.68M | 2.37% | 9 |
|
2019
Q3 | $32.8M | Buy |
301,942
+81,642
| +37% | +$8.87M | 2.23% | 16 |
|
2019
Q2 | $21.5M | Buy |
220,300
+7,400
| +3% | +$721K | 1.47% | 31 |
|
2019
Q1 | $19.4M | Buy |
+212,900
| New | +$19.4M | 1.42% | 34 |
|
2016
Q1 | – | Sell |
-226
| Closed | -$17K | – | 189 |
|
2015
Q4 | $17K | Buy |
+226
| New | +$17K | ﹤0.01% | 147 |
|